Allworth Financial’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.7K Buy
1,527
+1,204
+373% +$33.9K ﹤0.01% 2620
2026
Q1
$9.22K Buy
323
+295
+1,054% +$10.1K ﹤0.01% 3564
2025
Q4
$1.11K Sell
28
-5
-15% -$183 ﹤0.01% 4328
2025
Q3
$1.16K Buy
33
+23
+230% +$792 ﹤0.01% 4203
2025
Q2
$328 Buy
10
+4
+67% +$130 ﹤0.01% 4227
2025
Q1
$203 Buy
+6
New +$223 ﹤0.01% 3869
2024
Q4
– Sell
-26
Closed -$730 – 3947
2024
Q3
$730 Sell
26
-69
-73% -$1.7K ﹤0.01% 3329
2024
Q2
$2.3K Buy
95
+73
+332% +$1.69K ﹤0.01% 2860
2024
Q1
$670 Hold
22
– – ﹤0.01% 3201
2023
Q4
$786 Sell
22
-104
-83% -$3.87K ﹤0.01% 3033
2023
Q3
$5.52K Sell
126
-43
-25% -$2.1K ﹤0.01% 2063
2023
Q2
$8.34K Sell
169
-100
-37% -$4.61K ﹤0.01% 1918
2023
Q1
$11.2K Buy
+269
New +$11.2K ﹤0.01% 1753
2022
Q2
– Sell
-169
Closed -$11K – 2384
2022
Q1
$11K Buy
+169
New +$11K ﹤0.01% 1453

Other funds holding ATRC

Allworth Financial's ATRC Position: Q2 2026 in Review

Allworth Financial increased its AtriCure (ATRC) stake by 373% in Q2 2026, buying an estimated $33.9K and bringing the position to 1,527 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Allworth Financial first reported a position in ATRC in Q1 2022 and has held it in 14 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Allworth Financial held 1,527 shares of AtriCure worth $42.7K as of Q2 2026.
  • Allworth Financial bought 1,204 AtriCure shares in Q2 2026, an estimated $33.9K.
  • AtriCure made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2620 holding.
  • Allworth Financial first reported a position in AtriCure in Q1 2022 and has held it in 14 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.